Saba Capital Amends Filing for Neuberger Berman Municipal Fund

TL;DR

Saba Capital updated its 13D filing for Neuberger Berman Municipal Fund. Watch this space.

AI Summary

Saba Capital Management, L.P. has filed an amendment (Amendment No. 2) to its Schedule 13D on April 11, 2024, regarding its holdings in Neuberger Berman Municipal Fund Inc. The filing indicates a change in the reporting person's beneficial ownership of the common shares of the issuer.

Why It Matters

This filing signals potential shifts in significant shareholder positions within Neuberger Berman Municipal Fund, which could influence the fund's future strategy or performance.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate activist intentions or significant trading activity, warranting closer monitoring.

Key Players & Entities

• Saba Capital Management, L.P. (company) — Reporting Person
• Neuberger Berman Municipal Fund Inc. (company) — Issuer
• Boaz R. Weinstein (person) — Group Member

FAQ

Key Financial Figures

• $0.0001 — D INC (Name of Issuer) Common Shares, $0.0001 par value (Title of Class of Securitie
• $17,361,762 — ported herein. A total of approximately $17,361,762 was paid to acquire the Common Shares r

Filing Documents

• formsc13da.htm (SC 13D/A) — 59KB
• 0001062993-24-008291.txt ( ) — 61KB

is hereby amended and supplemented as follows

Item 4 is hereby amended and supplemented as follows: On April 9, 2024, Saba Capital Master Fund, Ltd., a private fund advised by Saba Capital, submitted to the Issuer a notice of intent informing the Issuer of its intention to nominate Paul Kazarian (the " Nominee ") as an independent director for election at the Issuer's 2024 annual meeting of shareholders (the " Annual Meeting "). Item 5. INTEREST IN SECURITIES OF THE ISSUER (a) See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 29,618,059 shares of common stock outstanding as of 10/31/23, as disclosed in the company's N-CSR filed 1/5/24. (b) See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. (c) The transactions in the Common Shares effected in the last sixty days by the Reporting Persons are set forth in Schedule A and are incorporated herein by reference. (d) The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares. (e) Not applicable. CUSIP No. 64124P101 SCHEDULE 13D/A Page 6 of 7 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: April 11, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 64124P101 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital in the past sixty days. Trade Date Buy/Sell Shares Price 2/15/2024 Buy 4 10.41 3/15/2024 Buy 3 10.47

View Full Filing

View this SC 13D/A filing on SEC EDGAR